Literature DB >> 34955408

Aggressive disseminated Rhizomucor pusillus infection in a Ph-like acute lymphoblastic leukemia patient: Early detection by cell-free DNA next-generation sequencing.

Liming Shi1, Xiaoxia Zhao1, Xu Yan2, Yu Liu1, Yong Liu3, He Cao1, Keju Su1, Cong Wang1, Sujun Gao1, Qiuju Liu4.   

Abstract

Disseminated Rhizomucor pusillus infection is a very rare but fatal complication in immunocompromised patients, because of aggressive clinical process with delayed diagnosis by routine laboratory tests. Recently, cell-free DNA next-generation sequencing (cfDNA NGS) has been used for the timely detection of infectious pathogens including mucormycosis. Herein, we described an 18-year-old male with Philadelphia-like acute lymphoblastic leukemia who received a timely diagnosis of R. pusillus infection by cell-free DNA next-generation sequencing, and confirmed by silver staining and qPCR on biopsy tissue. To the best of our knowledge, this was the first case of disseminated R. pusillus infection detected by cfDNA NGS and confirmed by histology in an adult leukemia patient. In addition, this case was supposed to be the most extensive R. pusillus infection diagnosed, involving the lung, skin, liver, kidney, spleen and brain, and the only one case who survived the infection had a favorable outcome through treatment with liposome amphotericin B sequential posaconazole. This case suggested that cfDNA NGS could be used to successfully detect rare pathogen infections, and this was especially important for R. pusillus because timely diagnosis and effective treatment could improve the prognosis of this kind of patient.
Copyright © 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CfDNA; Disseminated infection; Next-generation sequencing; Rhizomucor pusillus

Mesh:

Substances:

Year:  2021        PMID: 34955408     DOI: 10.1016/j.jiac.2021.12.007

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  4 in total

Review 1.  Recent Advances and Future Directions in the Understanding of Mucormycosis.

Authors:  Victoriano Garre
Journal:  Front Cell Infect Microbiol       Date:  2022-02-24       Impact factor: 5.293

2.  Clinical presentations, diagnosis, management, and outcomes of renal mucormycosis: An overview of case reports.

Authors:  Mojtaba Didehdar; Zahra Chegini; Amin Khoshbayan; Alireza Moradabadi; Aref Shariati
Journal:  Front Med (Lausanne)       Date:  2022-08-24

3.  Nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: Early detection by metagenomic next-generation sequencing.

Authors:  Qing Zhang; Xingchen Liu; Yanyan Liu; Huiqin Wang; Ran Zhao; Xiaodong Lv; Xudong Wei; KeShu Zhou
Journal:  Front Cell Infect Microbiol       Date:  2022-09-16       Impact factor: 6.073

4.  COVID-19-associated disseminated mucormycosis: An autopsy case report.

Authors:  Daisuke Kyuno; Terufumi Kubo; Mitsuhiro Tsujiwaki; Shintaro Sugita; Michiko Hosaka; Hazuki Ito; Keisuke Harada; Akira Takasawa; Yusaku Kubota; Kumi Takasawa; Yusuke Ono; Kazufumi Magara; Eichi Narimatsu; Tadashi Hasegawa; Makoto Osanai
Journal:  World J Clin Cases       Date:  2022-10-06       Impact factor: 1.534

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.